By the end of 2017, CTS has secured three source plasma partners and continues to seek additional partners in the plasma industry in order to continue to diversify CTS’s revenue stream.
In January, CTS is incorporated as a non-profit organization owned by Vitalant and OneBlood (formerl...
Transitioned all 6 CTS labs from an investigational new drug (IND) to a licensed Zika test, and anno...
CTS Tampa lab implemented the Ortho Clinical Diagnostics VITROS® testing platform to perform COVID-1...
In April, CTS becomes the first blood donor testing organization in the US to implement Zika testing...
CTS merges with the three Red Cross testing laboratories located in Charlotte, Portland and St. Loui...
Continue to meet or exceed healthcare partners’ expectations by providing on-time test results appr...